Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study

Novel SARS coronavirus or SARS-CoV-2 is a novel coronavirus that was identified and spread from Wuhan in 2019. On January 30th, the World Health Organization declared the coronavirus outbreak as a Global Public Health Emergency. Although Remdesivir and Molnupiravir are FDA-approved drugs for COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahbazi, Behzad, Mafakher, Ladan, Teimoori-Toolabi, Ladan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898033/
https://www.ncbi.nlm.nih.gov/pubmed/35249180
http://dx.doi.org/10.1007/s00894-022-05059-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898033/
https://www.ncbi.nlm.nih.gov/pubmed/35249180
http://dx.doi.org/10.1007/s00894-022-05059-1

Ejemplares similares